Growth opportunities: Let's talk
Since its creation, Valeo Pharma successfully acquired or licensed a variety of more than 15 niche brands while maintaining the high-level quality of distribution and service.

We continue to aggressively seek other opportunities with Canadian and international pharmaceutical companies. At the moment, Valeo Pharma enjoys a solid portfolio of OTC and prescription brands, particularly in the dermatology category. We are also interested in expanding our expertise in other specialty sectors of the pharmaceutical industry.

In 2006 alone, we reintroduced the antitussive Cophylac as well as the Injectable Aristospan
(which no longer required the Health Canada Special Access Program approval) to the market.
We have also launched Hydrosal® a new first-line topical gel treatment for excessive sweating.

If you are interested in talking to us regarding one of your products, please contact Steve Saviuk, President of Valeo Pharma Inc

Steve can be reached at: 1-866 694-0150, extension 830, or by e-mail at: Saviuk@valeopharma.com